Atıf Formatları
Clinical effıcacy of omalizumab in severe persistent asthma and co-morbid conditions.
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

S. GÜMÜŞLÜ, "Clinical effıcacy of omalizumab in severe persistent asthma and co-morbid conditions.," Türk Toraks Derneği 14. Yıllık Kongresi , Antalya, Turkey, pp.101-102, 2011

GÜMÜŞLÜ, S. 2011. Clinical effıcacy of omalizumab in severe persistent asthma and co-morbid conditions.. Türk Toraks Derneği 14. Yıllık Kongresi , (Antalya, Turkey), 101-102.

GÜMÜŞLÜ, S., (2011). Clinical effıcacy of omalizumab in severe persistent asthma and co-morbid conditions. . Türk Toraks Derneği 14. Yıllık Kongresi (pp.101-102). Antalya, Turkey

GÜMÜŞLÜ, SAADET. "Clinical effıcacy of omalizumab in severe persistent asthma and co-morbid conditions.," Türk Toraks Derneği 14. Yıllık Kongresi, Antalya, Turkey, 2011

GÜMÜŞLÜ, SAADET. "Clinical effıcacy of omalizumab in severe persistent asthma and co-morbid conditions.." Türk Toraks Derneği 14. Yıllık Kongresi , Antalya, Turkey, pp.101-102, 2011

GÜMÜŞLÜ, S. (2011) . "Clinical effıcacy of omalizumab in severe persistent asthma and co-morbid conditions.." Türk Toraks Derneği 14. Yıllık Kongresi , Antalya, Turkey, pp.101-102.

@conferencepaper{conferencepaper, author={SAADET GÜMÜŞLÜ}, title={Clinical effıcacy of omalizumab in severe persistent asthma and co-morbid conditions.}, congress name={Türk Toraks Derneği 14. Yıllık Kongresi}, city={Antalya}, country={Turkey}, year={2011}, pages={101-102} }